Abstract:BackgroundKetamine, a robust antidepressant, has promising potential in the treatment of major depressive disorder (MDD). However, it does not work for all MDD patients, and the mechanism underlying its anti-depressive effects is unclear. Researchers have explored the mechanisms of ketamine action in MDD patients through MRI, a technique that measures brain activity intuitively. Notably, many MRI results were inconsistent because they selected different brain regions as seeds, particularly with respect to functional connectivity (FC) analysis. To eliminate the influence of prior seeds as much as possible, we used the significantly different results in degree centrality (DC) analysis as seeds to explore the FC changes in MDD patients to identify an imaging biomarker of ketamine's effect. MethodsForty-four MDD patients and 45 healthy controls (HCs) were included in the study. Patients, aged 18-65, received six intravenous ketamine injections over 12 days. Depressive symptoms were estimated and MRI scans were performed at baseline and the day after the sixth infusion. We estimated FC differences between responders, non-responders and HCs using the region that showed significant differences between responders and non-responders in DC analysis as the seed. The correlation between the MADRS changes and zFC values was performed, and the potential of zFC values to be a neuroimaging biomarker was explored using the receiver operating characteristic curve. ResultCompared with non-responders, responders had significantly decreased DC values in the right middle frontal gyrus (MFG). In the analysis of FC using the region that showed significant differences in DC as a seed, there was a significant difference in the region of the right supplementary motor area (SMA) among responders, non-responders, and HCs. This region also overlapped with the bilateral median cingulate gyrus. In post hoc analysis, responders had higher FC than non-responders and HCs, and non-responders had lower FC than HCs. Importantly, the FC between the MFG and SMA (overlapping bilateral median cingulate gyrus) was correlated with the improvement of symptoms, which was estimated by the Mongomery-Asberg Depression Scale (MADRS). FC has the potential to be an imaging biomarker that can predict the ketamine effect in MDD patients according to the receiver operating characteristic curve analysis. ConclusionOur results revealed that FC between the SMG and SMA and mACC was highly correlated with depressive symptoms and has the potential to be a neuroimaging biomarker to predict the effect of ketamine in MDD.

The Functional Connectivity of the Middle Frontal Cortex Predicts Ketamine’s Outcome in Major Depressive Disorder

Functional Connectivity of the Amygdala and the Antidepressant and Antisuicidal Effects of Repeated Ketamine Infusions in Major Depressive Disorder

Functional Connectivity Differences in the Amygdala Are Related to the Antidepressant Efficacy of Ketamine in Patients with Anxious Depression

Ketamine-induced hippocampal functional connectivity alterations associated with clinical remission in major depression.

Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression

Pre-treatment Functional Connectivity of the Cingulate Cortex Predicts Anti-Suicidal Effects of Serial Ketamine Infusions

Functional Connectivity of the Hippocampus in Predicting Early Antidepressant Efficacy in Patients with Major Depressive Disorder.

Abnormal Dynamic Functional Connectivity of the Left Rostral Hippocampus in Predicting Antidepressant Efficacy in Major Depressive Disorder

Study on Functional Connectivity Between the Subgenual Anterior Cingulate Cortes and Limbic Cortices in Predicting the Efficacy of Early Antidepressant Treatment Outcome

Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals

Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine

Identification of Major Depressive Disorder and Prediction of Treatment Response Using Functional Connectivity Between the Prefrontal Cortices and Subgenual Anterior Cingulate: A Real-World Study

The Neurobiological Mechanism Underlying Ketamine’s Rapid-Acting Antidepressant Effect

Baseline Patterns of Resting Functional Connectivity Within Posterior Default-Mode Intranetwork Associated with Remission to Antidepressants in Major Depressive Disorder

Contribution of resting-state functional connectivity of the subgenual anterior cingulate to prediction of antidepressant efficacy in patients with major depressive disorder

Biomarkers of ketamine's antidepressant effect: An umbrella review

Serum Interleukin-6 is a Predictive Biomarker for Ketamine’s Antidepressant Effect in Treatment-Resistant Patients with Major Depression

The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality

Predict Value of Functional Topological Features for Early Response to Antidepressant Treatment in Major Depressive Disorder

Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study

Immediate and long-term electrophysiological biomarkers of antidepressant-like behavioral effects after subanesthetic ketamine and medial prefrontal cortex deep brain stimulation treatment